STAT Plus Pharmalittle Pfizer offers early retirement ahead of layoffs; Novartis buys Endocyte for $2.1 billion

STAT Plus: Pharmalittle: Pfizer offers early retirement ahead of layoffs; Novartis buys Endocyte for $2.1 billion

09:14 EDT 18 Oct 2018 | STAT

Novartis agreed to pay $2.1 billion to acquire Endocyte in order to gain access to a new treatment being developed for prostate cancer.